Bladder Cancer

Mark S. Litwin, MD, MPH

Specialty: Bladder Cancer, Kidney Cancer, Minimally Invasive Surgery, Prostate Cancer, Testicular Cancer, Urologic Oncology

Practice Location: Urology, Westwood Adult

Chair, Department of Urology. Professor of Urology, Health Policy & Management, and Nursing. He trained at Harvard and specializes in testicular, bladder, prostate and kidney cancer. Dr. Litwin’s research focuses on improving quality of care, quality of life, and equitable access to care in urologic oncology. He created and directs IMPACT, a state-funded program that provides free medical care statewide for low-income, uninsured men with prostate cancer. He also leads several national and international research projects in prostate cancer, funded by the American Cancer Society, US Department of Defense, and Movember Foundation. He directs an NIH-funded fellowship training program in outcomes research in urologic oncology. Dr. Litwin is Founder and Co-Director of the UCLA Gender Health Program. For 14 years, he led Urologic Diseases in America, the NIH’s largest effort at documenting the burden of urologic diseases on the American people. More >

Karim Chamie, MD, MSHS

Specialty: Bladder Cancer, Clinical Trials, Kidney Cancer, Minimally Invasive Surgery, Prostate Cancer, Urologic Oncology

Practice Location: Urology, Westwood Adult

Associate Professor-in-Residence of Urology and Society of Urologic Oncology Fellowship Director. He attended Medical School at USC and completed Urological training at UC Davis. Dr. Chamie then completed a SUO certified fellowship in Urologic Oncology at UCLA. His primary research interests are health services research and clinical trials in bladder cancer. His clinical interests include all areas of urologic oncology, with a particular emphasis on bladder cancer and robotic surgery. More >

Arnold I. Chin, MD, PhD

Specialty: Bladder Cancer, Kidney Cancer, Minimally Invasive Surgery, Prostate Cancer, Urologic Oncology

Practice Location: Urology, Westwood Adult

Associate Professor of Urology and Medical Director, Urology-Westwood. Dr. Chin completed his M.D., Ph.D. and Urology residency training at UCLA. His clinical expertise includes urologic oncology and renal transplantation. He performs open, laparoscopic, and robotic-assisted surgeries for patients with all urologic malignancies including bladder, kidney, and prostate cancer. Dr. Chin's laboratory at the UCLA Broad Stem Cell Research Center studies the differentiation of bladder cancer and its interplay with the tumor microenvironment. The long-term goals are to develop novel therapeutic targets, immune-based platforms, and stem cell-directed therapies against cancer. Dr. Chin's research has led to an investigator-initiated clinical trial that he is leading for patients with advanced small cell-neuroendocrine bladder and prostate cancer. More >

Mark S. Litwin, MD, MPH

Specialty: Bladder Cancer, Kidney Cancer, Minimally Invasive Surgery, Prostate Cancer, Testicular Cancer, Urologic Oncology

Practice Location: Urology, Westwood Adult

Chair, Department of Urology. Professor of Urology, Health Policy & Management, and Nursing. He trained at Harvard and specializes in testicular, bladder, prostate and kidney cancer. Dr. Litwin’s research focuses on improving quality of care, quality of life, and equitable access to care in urologic oncology. He created and directs IMPACT, a state-funded program that provides free medical care statewide for low-income, uninsured men with prostate cancer. He also leads several national and international research projects in prostate cancer, funded by the American Cancer Society, US Department of Defense, and Movember Foundation. He directs an NIH-funded fellowship training program in outcomes research in urologic oncology. Dr. Litwin is Founder and Co-Director of the UCLA Gender Health Program. For 14 years, he led Urologic Diseases in America, the NIH’s largest effort at documenting the burden of urologic diseases on the American people. More >

Allan Pantuck, MD, MS, FACS

Specialty: Bladder Cancer, Clinical Trials, General Adult Urology, Kidney Cancer, Prostate Cancer, Urologic Oncology

Practice Location: Urology, Westwood Adult

Professor of Urology and Vice Chair of Academic Affairs for Urology. Dr. Pantuck specializes in urologic cancers and has a long standing interest in kidney, prostate, bladder cancers, developing new treatment strategies through basic and clinical research and in the study of nutritional approaches to their prevention and treatment. More >

Robert E. Reiter, MD

Specialty: Bladder Cancer, Clinical Trials, Minimally Invasive Surgery, Prostate Cancer, Urologic Oncology

Practice Location: Urology, Westwood Adult

Professor of Urology, Professor of Molecular Biology, Chief of the Division of Urologic Oncology, Director of the Prostate Cancer Program, Co-Director of the Genitourinary Oncology Program in UCLA's Jonsson Cancer Center. Dr. Reiter attended Stanford Medical School, completed urologic training at Stanford and Baylor College of Medicine, completed additional fellowship training in urological cancer at the National Cancer Institute. His clinical interests include all areas of urologic oncology, with an emphasis on prostate cancer. He specializes in robotically-assisted prostatectomy and cystectomy, as well as open surgery, with robotic experience dating back to 2004, for bladder, prostate, and renal malignancies. Dr. Reiter is involved in all aspects of urologic oncology, with an emphasis on prostate cancer, and brings extensive experience in robotic surgery and the applications of translational research and the latest in MRI and molecular imaging to the management of men with this disease. More >

Christopher Saigal, MD, MPH

Specialty: Bladder Cancer, General Adult Urology, Kidney Cancer, Kidney Stone Center, Minimally Invasive Surgery, Prostate Cancer, Testicular Cancer, Urologic Oncology

Practice Locations: Urology, Westwood Adult

Professor and Vice Chair, Urology. Clinical practice, UCLA Westwood Campus. He is also on the staff of the West Los Angeles Veterans Affairs Medical Center. Dr. Saigal has had a longstanding clinical interest in urologic cancers and the surgical treatment of benign prostatic hyperplasia. His research is focused on patient-centered decision support and quality of care for urologic conditions. More >